pomalidomide has been researched along with gdc-0068 in 1 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (gdc-0068) | Trials (gdc-0068) | Recent Studies (post-2010) (gdc-0068) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 62 | 17 | 60 |
| Protein | Taxonomy | pomalidomide (IC50) | gdc-0068 (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.157 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.0418 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.0255 | |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | 0.0835 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.0187 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cahuzac, KM; Chen, X; Jin, J; Liu, J; Parsons, RE; Shen, Y; Wang, L; Xie, L; Xu, J; Yu, X | 1 |
1 other study(ies) available for pomalidomide and gdc-0068
| Article | Year |
|---|---|
Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders.
Topics: Animals; Biological Availability; Cell Line, Tumor; Drug Design; Humans; Mice; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Structure-Activity Relationship | 2021 |